December 20, 2018, News Medical 

Researchers at the Queen Mary University of London have developed a new cervical cancer test that proved to be 100 percent effective at detecting the cancer in a trial of 15,744 participants. The study demonstrated that the epigenetics-based test outperformed both the Pap smear and the human papilloma virus (HPV) test, as well as being more cost effective. 

Read more.